The KEGG analysis showed that the DEGs in the high-risk and low-risk patients identified in the present study were enriched in tumor-related pathways, including in the PI3K-Akt signaling pathway, focal adhesion, MAPK signaling pathway, and in proteoglycans in cases of cancer. This evidence concerns the gene AKT1 and neoplasm.